株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

将来の米国の微生物検査市場の展望

US Microbiology Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

発行 Venture Planning Group 商品コード 231311
出版日 ページ情報 英文 1037 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。

Local License: 同一事業所内

Back to Top
将来の米国の微生物検査市場の展望 US Microbiology Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
出版日: ページ情報: 英文 1037 Pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、米国における微生物検査市場の最新動向と将来展望について分析し、検査技術の研究開発の最新動向、世界市場の概況、米国市場の基本構造・動向、今後10年間の市場動向予測、市場拡大のための戦略と課題、主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • 主な感染症の検査(全68種)
    • エイズ(AIDS)
    • アデノウイルス
    • エロモナス
    • 炭疽病/炭疽菌
    • アルボウイルス
    • バベシア症
    • 細菌性血管腫症(BEA)
    • ブルセラ菌
    • カンピロバクター
    • カンジダ
    • シャーガス病
    • 軟性下疳
    • クラミジア
    • クロストリジウム・ディフィシレ
    • コロナウイルス
    • コクサッキーウイルス
    • クロイツフェルト・ヤコブ病
    • クリプトスポリジウム
    • シクロスポラ
    • サイトメガロ・ウイルス
    • エボラウイルス
    • 大腸菌
    • エコー・ウイルス
    • 脳炎
    • エンテロウイルス
    • エプスタイン・バーウイルス
    • ランブル鞭毛虫
    • 淋病
    • 鼠径部肉芽腫
    • ハンタウイルス
    • ピロリ菌
    • 肝炎
    • 単純ヘルペスウイルス
    • ヒトヘルペス・ウイルス6型
    • インフルエンザウイルス
    • レジオネラ
    • ライム病
    • 鼠径リンパ肉芽腫
    • マラリア
    • はしか
    • 髄膜炎
    • 微胞子虫目
    • 単核症
    • おたふく風邪
    • マイコプラズマ
    • パピロマウイルス
    • パルボウイルス B19
    • 肺炎
    • ポリオーマウイルス
    • 緑膿菌
    • 狂犬病
    • 呼吸器合胞体ウイルス
    • ライノウイルス
    • ロタウイルス
    • 風疹
    • サルモネラ菌
    • 敗血症
    • 細菌性赤痢
    • 黄色ブドウ球菌
    • 連鎖球菌
    • 梅毒
    • トキソプラズマ症
    • 膣トリコモナス
    • 結核
    • ビブリオ
    • 西ナイルウイルス
    • エルシニア
  • 診断装置のレビューと市場のニーズ(全23種)
  • 新規の診断技術
    • DNAプローブ
    • モノクローナル抗体
    • 免疫学的検定
    • 差分光散乱
    • マイクロコンピュータ・オートメーション
    • 人工知能
    • リポソーム
    • フローサイトメトリ
    • クロマトグラフィ
    • MRI
    • ゲル微液滴
    • その他

米国市場

  • エグゼクティブ・サマリー
  • ビジネス環境
    • 医療費支出
    • コスト意識
    • 医療費還付
    • 産業内の企業統合
    • マネージドケア(管理型医療)
    • 病院
    • 入院
    • 滞在期間
    • 産業の多様化
    • 医師の人口構成
    • 人口の高齢化
    • 研究機関に対する規制
    • FDAの改革
  • 市場構造
    • 集中型検査
    • 分散型検査
  • 市場規模・成長率・主要サプライヤー

主な製品開発機会

  • 機器
  • 試薬キットおよび検査システム/パネル
  • コンピューター・ソフトウェア・オートメーション
  • 補助製品

分散型検査製品の設計基準

代替的な市場浸透戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業分析

  • Abbott
  • Affymetrix
  • Beckman Coulter
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • J&J Diagnostics
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen
  • Novartis Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac
  • 和光純薬工業

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMG20514

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
  
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories
     ° Physician Offices/Group Practices
     ° Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.

Contains 1,037 pages and 177 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

  • 1. AIDS
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 2. Adenovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • d. Adeno-Associated Viruses(AAV)
  • 3. Aeromonas
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 4. Anthrax/Bacillus Anthracis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 5. Arboviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 6. Babesiosis
    • a. Background
  • 7. Bacillary Epithelioid Angiomatosis (BEA)
    • And Other Bartonella (Rochalimaea)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 8. Blastocystis Hominis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 9. Brucella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 10. Campylobacter
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 11. Candida
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 12. Chagas Disease
    • a. Background
  • 13. Chancroid
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 14. Chlamydia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 15. Clostridium Difficile
    • a. Background
    • b. Diagnostic Tests
    • c. Drugs and Vaccines
  • 16. Coronaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 17. Coxsackieviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 18. Creutzfeldt-Jakob's Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines
  • 19. Cryptosporidium Parvum
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 20. Cyclospora Cayetanensis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 21. Cytomegalovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 22. Ebola Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 23. E. Coli
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 24. EchoVirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 25. Encephalitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 26. Enteroviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 27. Epstein-Barr Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 28. Giardia Lamblia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 29. Gonorrhea
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 30. Granuloma Inguinale
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 31. Hantavirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 32. Helicobacter Pylori
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 33. Hepatitis
    • a. Background
    • b. Hepatitis A
    • c. Hepatitis B
    • d. Hepatitis C
    • e. Vaccines and Drugs
  • 34. Herpes Simplex Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 35. Human Herpes Virus-6 (HHV-6)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 36. Influenza Viruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 37. Legionella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 38. Lyme Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 39. Lymphogranuloma Venereum (LGV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 40. Malaria
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 41. Measles (Rubeola)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 42. Meningitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 43. Microsporidium
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 44. Mononucleosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 45. Mumps
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 46. Mycoplasma
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 47. Papillomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 48. Parvovirus B19
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 49. Pneumonia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 50. Polyomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 51. Pseudomonas Aeruginosa
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 52. Rabies
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 53. Respiratory Syncytial Virus (RSV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 54. RhinoViruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 55. RotaVirus (REOVIRUS)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 56. Rubella(MEASLES)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 57. Salmonellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 58. Septicemia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 59. Shigellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 60. Staphylococcus Aureus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 61. Streptococci
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 62. Syphilis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 63. Toxoplasmosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 64. Trichomonas Vaginalis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 65. Tuberculosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 66. Vibrio
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 67. West Nile Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 68. Yersina
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers

C. Emerging Diagnostic Technologies

  • 1. Molecular Diagnostics
  • 2. Monoclonal Antibodies
  • 3. Immunoassays
  • 4. Differential Light Scattering
  • 5. Information Technology
  • 6. Artificial Intelligence
  • 7. Liposomes
  • 8. Flow Cytometry
  • 9. Chromatography
  • 10. Diagnostic Imaging
  • 11. Gel Microdroplets
  • 12. Other

U.S.A.

  • A. Executive Summary
  • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Reimbursement
    • 4. Industry Consolidation
    • 5. Managed Care
      • a. HMO
      • b. PPO
    • 6. Hospitals
    • 7. Admissions
    • 8. Length of Stay
    • 9. Industry Diversification
    • 10. Physician Demographics
    • 11. Population Aging
      • a. Chronic Illness
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 12. Laboratory Regulations
    • 13. FDA Reform

C. Market Structure

  • 1. Centralized Testing
    • a. Hospitals
    • b. Commercial/Private Laboratories
    • c. Blood Banks
      • 1) Community and Regional Centers
      • 2) Plasma Fractionation Centers
  • 2. Decentralized Testing
    • a. Physician Offices/Group Practices
    • b. Point of Care Testing
    • c. Other Decentralized Testing Locations

D. Market Size, Growth and Major Suppliers Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • U.S.A. Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment
  • U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
  • U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
  • U.S.A. All Market Segments Infectious Disease Test Volume Forecast
  • U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. Blood Banks Infectious Disease Test Volume Forecast
  • U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
  • U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
  • U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.EBV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.s.a. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Back to Top